Animal trials of ICMR (Indian Council of Medical Research) Bharat Biotech International Limited’s COVID-19 vaccine candidate, have been successful.
Bharat Biotech tweeted on Friday i.e. 11th September, “Bharat Biotech proudly announces the animal study results of COVAXIN – These results demonstrate the protective efficacy in a live viral challenge model,”
Bharat Biotech has said in a release, “One group was administered a placebo while three groups were immunised with three different vaccine candidates at 0 and 14 days. All the macaques were challenged with SARS-CoV-2 14 days after the second dose. The protective response was observed with increasing SARS-CoV-2 specific IgG and neutralising antibody titres from third week post-immunisation.”
